Skip to Main Content

Author Details

Peter W Laird
Van Andel Institute
1985
211
97
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36596913Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer's Disease.Cell Mol Neurobiol2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36939385DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer.Cancer Res2023
36596913Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer's Disease.Cell Mol Neurobiol2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36939385DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer.Cancer Res2023
35321550How epigenomics broke the mold: an interview with Peter W Laird.Epigenomics2022
36040373High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities.Cancer Res2022
36347867Cell division drives DNA methylation loss in late-replicating domains in primary human cells.Nat Commun2022
35873672DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse.Cell Genom2022
35321550How epigenomics broke the mold: an interview with Peter W Laird.Epigenomics2022
35873672DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse.Cell Genom2022
36040373High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities.Cancer Res2022
36347867Cell division drives DNA methylation loss in late-replicating domains in primary human cells.Nat Commun2022
32339229The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.J Natl Cancer Inst2021
32339229The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.J Natl Cancer Inst2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33217343Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Cancer Cell2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33217343Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Cancer Cell2021
33015524Systematic Assessment of Tumor Purity and Its Clinical Implications.JCO Precis Oncol2020
33015524Systematic Assessment of Tumor Purity and Its Clinical Implications.JCO Precis Oncol2020
33216844Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas.Oncotarget2020
33216844Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas.Oncotarget2020
31037156Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).Theranostics2019
30985765In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression.J Vis Exp2019
31037156Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).Theranostics2019
31481539Differences in Genome-wide DNA Methylation Profiles in Breast Milk by Race and Lactation Duration.Cancer Prev Res (Phila)2019
31481539Differences in Genome-wide DNA Methylation Profiles in Breast Milk by Race and Lactation Duration.Cancer Prev Res (Phila)2019
30985765In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression.J Vis Exp2019
29224160MethyLight and Digital MethyLight.Methods Mol Biol2018
30361341The chromatin accessibility landscape of primary human cancers.Science2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
30085201SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions.Nucleic Acids Res2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
29625050Oncogenic Signaling Pathways in The Cancer Genome Atlas.Cell2018
29625051Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.Cell2018
29625048Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Cell2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29224160MethyLight and Digital MethyLight.Methods Mol Biol2018
29617664Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Cell Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29610480DNA methylation loss in late-replicating domains is linked to mitotic cell division.Nat Genet2018
29642018A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.Cell Rep2018
29635542Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.Ann Oncol2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
30085201SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions.Nucleic Acids Res2018
30361341The chromatin accessibility landscape of primary human cancers.Science2018
29617664Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Cell Rep2018
  • 1 - 50 of 422

Recommended Authors

Christopher F Bassil
Duke University School of Medicine Durham
Career Start Year 2013
Number of shared co-authors 1
Pavlo Lutsik
Catholic University (KU) Leuven
Career Start Year 2010
Number of shared co-authors 5
John P Thomson
MRC Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2010
Number of shared co-authors 0
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 7
Anna R Poetsch
Technical University Dresden
Career Start Year 2009
Number of shared co-authors 5
Lukas Chavez
University of California San Diego
Career Start Year 2008
Number of shared co-authors 5
Leander Van Neste
Maastricht University Medical Center
Career Start Year 2007
Number of shared co-authors 8
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 5
Yassen Assenov
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 5
Claudia Gebhard
University Hospital Regensburg
Career Start Year 2006
Number of shared co-authors 0
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 31
Chol-Hee Jung
University of Melbourne
Career Start Year 2005
Number of shared co-authors 3
Brock C Christensen
Geisel School of Medicine, Dartmouth College
Career Start Year 2005
Number of shared co-authors 18
David Klinkebiel
University of Nebraska Medical Center
Career Start Year 2005
Number of shared co-authors 0
Duncan Sproul
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2004
Number of shared co-authors 4
J??rg Tost
CEA-Institut de Biologie Francois Jacob, Universite Paris-Saclay
Career Start Year 2002
Number of shared co-authors 6
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Ting Wang
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 24
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 7
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 1
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 12
Francine E Garrett-Bakelman
University of Virginia
Career Start Year 1999
Number of shared co-authors 5
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 9
William M Grady
. Fred Hutchinson Cancer Center
Career Start Year 1997
Number of shared co-authors 29
Manon van Engeland
Maastricht University Medical Center
Career Start Year 1996
Number of shared co-authors 5
Dieter Weichenhan
German Cancer Research Center (DKFZ)
Career Start Year 1988
Number of shared co-authors 4
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 11
Kornel E Schuebel
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 8
Richard R Meehan
Institute of Genetics and Molecular Medicine, University of Edinburgh
Career Start Year 1984
Number of shared co-authors 0
Christoph Plass
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 19

Collaborators

Daniel J Weisenberger
Co-authored papers 53
Hui Shen
Van Andel Institute
Co-authored papers 43
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 23
Toshinori Hinoue
Co-authored papers 21
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 20
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 17
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Matthew Meyerson
Broad Institute
Co-authored papers 13
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 12
Robert W Haile
Co-authored papers 12
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 12
Reanne Bowlby
Co-authored papers 10
Benjamin P Berman
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Co-authored papers 10
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 10
Houtan Noushmehr
Henry Ford Hospital
Co-authored papers 10
Christopher C Benz
Buck Institute for Research on Aging
Co-authored papers 9
Charles M Perou
Co-authored papers 9
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 9
Christina Yau
University of California San Francisco
Co-authored papers 8
David A Wheeler
Baylor College of Medicine
Co-authored papers 8
Martin Widschwendter
European Translational Oncology Prevention and Screening (EUTOPS) Institute
Co-authored papers 8
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 8
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers 8
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers 8
Jay Bowen
Nationwide Children's Hospital
Co-authored papers 7
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Rameen Beroukhim
Co-authored papers 7
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 7
Wanding Zhou
University of Pennsylvania
Co-authored papers 7
Release 1.2